Eric Ruderman

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin et al. · Arthritis & Rheumatism · 2005 · 905 citations

Medicine, Pharmacology, Pharmacotherapy +15

Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial

Richard K. Burt, Sanjiv J. Shah, Karin E. Dill et al. · The Lancet · 2011 · 565 citations

Medicine, Hematology, Immunology +15

Portability of an algorithm to identify rheumatoid arthritis in electronic health records

Robert J. Carroll, Will K Thompson, Anne E. Eyler et al. · Journal of the American Medical Informatics Association · 2012 · 248 citations · Full text

Computing, Biomedical Informatics, Health Informatics +15

Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open‐label clinical trial

Deborah Friedman, Carolina Llanos, Peter Izmirly et al. · Arthritis & Rheumatism · 2010 · 240 citations · Full text

Life Sciences, Cardiology, Immunology +14

Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis

Richard K. Burt, Maria Carolina Oliveira, Sanjiv J. Shah et al. · The Lancet · 2013 · 159 citations

Medicine, Cardiology, Hematology +17